Healthcare_Diksha

  Global Anti-Viral Drugs Market The global anti-viral drugs market has been evaluated as a growing market and it is expected that the market will touch high growth figures in future. The global  anti-viral drugs market size  is expected to grow with CAGR of ~6.9% during the forecast period. There has been consolidation of the market as a few players have come to dominate the market due to acquisitions and mergers. Anti-Viral Drugs Market - Highlights Anti-viral drugs are used to treat viral infections and are the only agents acting against viruses as either other drugs are ineffective or too toxic. The market segment of anti-viral drugs is driven by factors such as rise in healthcare expenditure, growing research and development investment, emergence of virus life-threatening diseases like bird flu, strong development pipeline and increasing incidence rates of viral infections particularly HIV. WHO has estimated that in 2015 about 36.7 million people are suffering from HIV/AIDS with 1

  Market Scope Market Research Future (MRFR) anticipates the  biosurgery market size  to attain a healthy CAGR around 7.0% from 2023 to 2030 (assessment period). Growth Boosters and Deterrents Major growth boosters in the biosurgery market include the escalating number of surgeries, especially in emerging countries such as Mexico, India, Brazil, and Japan. Soaring number of sports injuries, rising burden of obesity cases, and the surge in spinal issues worldwide have also raised the demand for biosurgeries. With manufacturers increasingly focusing on taking up exhaustive research and development initiatives to create cutting-edge and high performance biosurgery devices, the global market is deemed to witness strong growth in the following years. Moreover, innovations with respect to healthcare technologies and their rapid adoption by the industry should also underpin the market growth during the given period. The global market will get further boost from the expanding elderly populatio

  Key Players: The global market consist of players such as Ambu Inc, Boston Scientific Corporation, Cogentix Medical, Fujifilm Holdings Corporation, KARL STORZ GmbH & Co. KG, Olympus Corporation, PENTAX Medical, and Richard Wolf GmbH are some of the prominent players at the forefront of competition in the global bronchoscopes market and are profiled in MRFR Analysis report. Bronchoscopes Market - Overview According to a recent study report published by the Market Research Future analysts, the global  bronchoscopes market size  is growing at a moderate pace; mainly due to increasing prevalence of respiratory tract diseases such as lung cancer, and COPD among others; increasing preference for minimally invasive procedures and increasing number of disposable bronchoscopes procedures. Increasing geriatric population, and changing environmental conditions leading to high air pollution have also fuelled the growth of the market That being said, there are few obstacles as well in this ma

  Market Scope Market Research Future (MRFR) studied the global antibiotics market 2021 for the review period till 2030. As per MRFR analysis, the market of antibiotics is likely to register 4.8% CAGR over the analysis period. By 2030, the  antibiotics market size  value is expected to touch USD 51,835 Mn by. Drivers and Restrains Impacting Antibiotics Market The surge in cases of bacterial infections is creating the demand for antibiotics that can support the expansion of the market. The increase in cases of COVID 19 and sepsis induced by COVID-19 can boost the demand for high power antibiotics, which, in turn, can prompt the market expansion. The availability of different type of antibiotics, one which can stop bacteria from reproducing and another that can destroy them, across different countries to meet treatment requirements of patient can improve the impetus of the antibiotics market. increasing efforts by major companies for the formulation of advanced antibiotic products, rise

  Market Highlights It is estimated that the global  Idiopathic Pulmonary Fibrosis (IPF) Treatment market Size  is expected to register a CAGR of 12.3% during the forecast period of 2023 to 2030, with a market value of USD 2,237 million in 2030. IPF is a life-threatening condition of the lungs in which tissues becomes thickened, stiff, and scarred over a long period. The IPF treatment market is driven by various factors such as growing demand for minimally invasive procedures to diagnose and treat different chronic diseases, increasing geriatric population, along with the rising prevalence rates of IPF and other fibrotic diseases. However, the high cost of surgery and the unavailability of proper treatment options are expected to curb the growth of the IPF treatment market. The global  idiopathic pulmonary fibrosis market  is currently dominated by numerous market players. The key players are involved in new product launches and strategic collaborations to strengthen its market positio

  Market Scope As per the reports by MRFR, the  hemophilia treatment market size  is likely to project a robust CAGR of 6.10% during the review timeframe from 2022 to 2027. Market Drivers Hemophilia refers to a genetic disorder, usually hereditary, where the patient's blood lacks the needed proteins that help in blood coagulation. The condition could be severe, moderate, and mild. The global market for hemophilia treatment has been witnessing massive growth over recent years due to the increasing number of hemophilia cases, favorable government schemes & aggressive campaigning in several countries, and varied availability of therapies and medications. However, the growth of the hemophilia treatment cost hemophilia treatment market is anticipated to be hampered by the complications involved in the replacement therapies and higher costs associated with the recombinant products. Competitive Analysis The global market for hemophilia treatment has a strong competitive landscape with

  UTI treatment Market Overview: The market for Urinary Tract Infections (UTI) is a well- established space, flooding with the numerous treatment options ranging from Home remedies, Alternative medicines to Antibiotics. Due to the growing prevalence of UTI, the market for UTI Treatment is escalating exponentially. Acknowledging the exponential growth, the market is observing currently; Market Research Future (MRFR) in its recently published study report asserts that the  UTI Treatment market size  is forecasted to reach USD 9.89 Bn. by 2027 with a CAGR of 3.6 % from 2022 to 2027. In addition to the growing incidences of urinary tract infections, factors impacting the  UTI treatment Market  growth include the rise in hospital-borne infections or nosocomial infections, childbirth, old age, obesity, and the growing health awareness, especially towards women health. However, the rising cases of UTI associated with the usages of the catheter are considered as the largest risk factor support

  Overview The global  endoscopy device market size  will grow at a CAGR of 6.30% during the forecast period 2022 to 2027. The market for endoscopy device is set to reach a higher valuation in the years to come. As per endoscopy device market analysts, the global market is anticipated to witness growth owing to the factors such as increasing prevalence of chronic diseases as well as the development of endoscopy technologies. However, the endoscopy device market will face challenges and restraints due to stringent regulatory policies and diseases and complications caused by endoscopy products during the forecast period 2022 to 2027. The growing incidence of chronic diseases in the endoscopy device market will support the growth. As per endoscopy device market analysts, the endoscopy device market-based companies will face certain challenges during the 2022 to 2027. The endoscopy device market research report provides in-depth analysis of the accessory & processors, application, end

  Market Synopsis: Market Research Future (MRFR) has published a report stating that the global  injectable drug delivery devices market size  is marked to expand at a remarkable CAGR of 11.5% during the forecast period of 2022-2027 and reach the valuation of USD 31,900 Mn by the end of the forecast period. High prevalence of chronic diseases that require injectable drug delivery devices on a daily basis as part of the treatment procedures is one of the primary factors that are propelling the growth of the global injectable drug delivery devices market. Introduction of technologically advanced devices for subcutaneous administration of drugs such as wearable injectors and increasing adoption of self-injectable devices by the individuals suffering from diabetes are also leading to the significant expansion of the global injectable drug delivery devices market. However, high cost of products and risk of cross-contamination caused due to improper use of injectable devices are restraining

  Growing Government Support for Healthcare Research to Drive In Vitro Diagnostics Market The global  In-Vitro Diagnostics Market size  is expected to exhibit a strong 8.16% CAGR over the forecast period from 2023 to 2030, according to the latest research report from Market Research Future (MRFR). The global In-Vitro Diagnostics Market is mainly driven by the growing government support for healthcare research into discovering more potent, more accurately targeted medication for various diseases. This is likely to drive significant innovation in the healthcare research sector in the coming years, thus driving the in vitro diagnostics market over the forecast period. The report presents an analysis of the regional segmentation of the market in detail, covering North America, Europe, Asia Pacific, the Middle East, and Latin America to provide a comprehensive overview of the market dynamics in each region. Competitive leaderboard analysis is also done for the market by profiling the leadin

  Market Highlights The  assisted reproductive technology (ART) market size  is expected to witness tremendous growth owing to the rising prevalence of infertility in males as well as females. Other key factors such as the growing obesity among population, rising ovulation disorders, change to sedentary lifestyle, socioeconomic factors like postponement of marriage due to unemployment and others, growing consumption of unhealthy diet, increasing occurrence of polycystic ovarian syndrome (PCOS), and increasing prevalence of breast or ovarian and endometrial cancer, increase in smoking and alcohol consumption are contributing towards the growth.  However, factors such as, lower success rate, the high cost of artificial reproductive technology procedures, expensive treatments, raising ethical issues, chances of birth defects, the risk of prematurity and low birth weight in new-borns and side effects associated with hysterectomy procedures are expected to restrict the market growth during

  Market Highlights The global  hemostasis and tissue sealing agents market Size  is projected to grow at a CAGR of 8.6% over the forecast period. There has been increasing demand for such products as it reduces complication during surgical procedures. Moreover, large number of surgical procedures across the globe are impacting the growth of the market positively. Increasing numbers of surgery procedures worldwide is one of another reason for driving the growth of the hemostasis and tissue sealing agents market.  Surgeries are performed by making cut on the body which leads to the wound formation. Hemostasis and tissue sealing agents products are used in external surgical processes for reducing bleeding. For example, they are used in neurosurgical procedures, cardiac surgery, bariatric surgery, leg surgery, cesarean and orthopedic surgery. Hemostasis and tissue sealing agents products, are frequently used to reduce complexity and reduce recovery time after surgery. The high surgical pr

  Market Scope Market Research Future (MRFR) studied the global overactive bladder treatment market 2021 in the review period till 2030. As per MRFR daat, the  Overactive Bladder Treatment Market size  is expected to thrive at 3.1% CAGR during the forecast tenure (from 2022 to 2028). By 2030, the global overactive bladder treatment market is expected to earn decent value. Market Drivers and Restraints The rise in the number of patients with urinary urgency and high frequency, and nocturia; typically diagnosed with overactive bladder (OAB) can boost the need for effective treatment. The rise in occurrences of neurological diseases, especially among the growing geriatric group, can prompt the need for OAB management that can support the expansion of the global OAB market in the assessment period. In addition, upgradation and innovations of intravesical therapies and rapid commercialization of such new launches by pharma companies can prompt the market rise in the assessment tenure. On th

  Key Players: Some of the key players in the global intraocular lens market are Abbott Laboratories, Terumo Corporation, Cardinal Health Inc., Cardiva Medical Inc., Morris Innovative, Inc., Medtronic plc, Essential Medical, Inc., Merit Medical Systems, Inc., TZ Medical, Inc., Vasorum Ltd., Transluminal Technologies LLC, Vascular Closure Systems, Inc., Vivasure Medical Ltd., among others. Market Highlights It is estimated that the global  vascular closure devices market size  is expected to register a CAGR ~ 6.8% during the forecast period of 2023–2030. The global vascular closure devices market is expected to witness tremendous growth owing to the rising prevalence of numerous types of cardiovascular as well as neurovascular diseases. Other key factors such as the untapped market opportunities in emerging countries, growing investments by government organizations, increasing adoption rate of minimally invasive techniques are contributing towards the growth of the market. However, fact

  Dental Bone Graft Market – Synopsis Dental Bone Graft helps to support the socket a tooth is extracted from, and which would otherwise deform by the time an implant takes place. This further aids in protecting the bone from the receding jaw and stabilizes the adjacent teeth. Bone grafting is one of the most efficient solutions, allowing the dentist with the better flexibility, required at the time of implants or prosthetics and thus bettering the processes.  Bettered processes are increasingly encouraging people to opt for the Dental Bone Graft, augmenting its demand. Resultantly, the Dental Bone Graft market is growing pervasively. Growing Cosmetic Dentistry Treatment market, furthering the market size escalates the market globally. Increasing oral healthcare concerns worldwide, fuel the market growth predominantly. Increasing awareness among people about the oral health plays a major role in fostering the market growth. Considering the rapid expansions, the market is perceiving cur